The Poland patient engagement solutions market is projected to grow from $98.66 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, growing prevalence of chronic diseases, increasing healthcare expenditure and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players include Infermedica, Comarch Healthcare, Wolter Kluwer, Oracle and IBM.
The Poland patient engagement solutions market is projected to grow from $98.66 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. In 2019, Poland's national healthcare spending as a percentage of GDP was 6.45% or $1,014 per person. Poland has consistently spent less on health during the previous 10 years than the average EU country, both in terms of per-capita spending and as a percentage of GDP.
Poland's market for patient engagement solutions is expanding quickly as more patients and healthcare professionals become aware of the advantages of digital health solutions. Solutions for patient engagement include a variety of products and services that encourage patients to participate more actively in their healthcare, hence enhancing patient care and outcomes. The government is also investing in the development of digital health infrastructure, such as electronic health records and telemedicine, in order to increase access to healthcare services and facilitate the adoption of patient engagement solutions.
Market Growth Drivers
The Poland patient engagement solutions market is expected to be driven by factors such as the ageing population, growing prevalence of chronic diseases, increasing healthcare expenditure and government support. The Polish government has made significant investments in creating telemedicine and electronic health records infrastructure.
Market Restraints
Although digital health solutions are being adopted more widely in Poland, patients and healthcare professionals still have a limited understanding of the advantages of patient engagement solutions. For businesses engaged in this industry, this may result in low adoption rates, slow growth, and market contraction.
Key Players
January 2022: An investment round headed by One Peak totalling $30 Mn was announced by Infermedica. The funds will be used to support Infermedica in developing its Medical Guidance Platform (MGP) and adding new modules to cover the entire primary care journey in order to address some of the most pressing healthcare issues. Additionally, Infermedica will extend its multinational, remote-first staff of business and medical specialists in addition to its global commercial presence.
The Ministry of Health oversees Poland's well-established healthcare system. To enhance patient engagement and healthcare delivery, the nation has been aggressively developing regulations and laws. The National Health Program, which seeks to raise the standard of medical care and patient outcomes, is one of the main policies. The program's main goals are to improve patient access to healthcare services and increase patient engagement. To enhance patient participation and service delivery, the government has also created regulations requiring healthcare providers to embrace electronic health records and telemedicine systems.
Poland's regulatory structure for patient engagement solutions is favourable, and the country's leadership encourages the use of technology in healthcare. In order to protect patient's privacy and confidentiality, the Data Privacy Act and the EU General Data Protection Regulation (GDPR) both establish extensive requirements for the gathering, processing, and storage of patient data.
The National Health Fund (NFZ) in Poland is primarily in charge of regulating reimbursement procedures for patient engagement solutions. The NFZ is in charge of funding medical services, technologies, and patient involvement programs. Patient engagement solutions must be registered with the Office for Registration of Medicinal Goods, Medical Devices, and Biocidal Products (URPL) and adhere to strict requirements for safety, efficacy, and cost-effectiveness in order to be eligible for reimbursement. The NFZ decides the reimbursement amount, which is dependent on how cost-effective the solution is.
1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By component (Revenue, USD Billion):
By Delivery Mode (Revenue, USD Billion):
By Application (Revenue, USD Billion):
By Therapeutic area (Revenue, USD Billion):
By Functionality (Revenue, USD Billion):
By End-user (Revenue, USD Billion):
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.